1. 1239. Different Dose Levels of a Respiratory Syncytial Virus Maternal Vaccine Candidate (RSVPreF3) Administered to Non-pregnant Women in a Randomized Clinical Trial Are Immunogenic and Well Tolerated. (31st December 2020) Authors: Schwarz, Tino; Johnson, Casey; Grigat, Christine; Apter, Dan; Csonka, Peter; Lindblad, Niklas; Nguyen, Thi Lien-Anh; Gao, Feng F; Soni, Jyoti; Tullio, Antonella Nadia; Dieussaert, Ilse; Picciolato, Marta; Henry, Ouzama Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗